Company Accounts and Tax Online 15969567 Board of Directors 20.9.24 30.9.25 30.9.25 No description of principal activity false iso4217:GBP xbrli:pure 15969567 2025-09-30 15969567 2024-09-20 2025-09-30 15969567 countries:EnglandWales 2024-09-20 2025-09-30 15969567 curr:PoundSterling 2024-09-20 2025-09-30 15969567 uk-bus:PrivateLimitedCompanyLtd 2024-09-20 2025-09-30 15969567 uk-bus:Micro-entities 2024-09-20 2025-09-30 15969567 uk-bus:AuditExempt-NoAccountantsReport 2024-09-20 2025-09-30 15969567 uk-bus:FullAccounts 2024-09-20 2025-09-30 15969567 uk-bus:RegisteredOffice 2024-09-20 2025-09-30 15969567 uk-bus:Director1 2024-09-20 2025-09-30 15969567 uk-bus:Director1 2024-09-20 15969567 uk-bus:Director1 2025-09-30 15969567 core:AfterOneYear 2025-09-30 15969567 core:WithinOneYear 2025-09-30 15969567 core:WithinOneYear 2024-09-20 2025-09-30 15969567 core:AfterOneYear 2025-09-30 15969567 core:AfterOneYear 2024-09-20 2025-09-30 15969567 core:ShareCapital 2025-09-30 15969567 core:RevaluationReserve 2025-09-30 15969567 core:RetainedEarningsAccumulatedLosses 2025-09-30 15969567 1 2024-09-20 2025-09-30

# REFOLD THERAPEUTICS LIMITED

## Company Registration Number:
15969567 (England and Wales)

## Unaudited micro entity accounts for the year ended 30 September 2025

## Period of accounts

## Start date: 20 September 2024

## End date: 30 September 2025

# REFOLD THERAPEUTICS LIMITED

## Contents of the Financial Statements

for the Period Ended 30 September 2025

Company Information - 3 |
Profit and Loss Account - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# REFOLD THERAPEUTICS LIMITED

## Company Information

for the Period Ended 30 September 2025

Registered office: |  | International House 307 Cotton Exchange Old Hall Street Liverpool England L3 9LQ
Company Registration Number: |  | 15969567 (England and Wales)

# REFOLD THERAPEUTICS LIMITED

## Profit and Loss Account

for the Period Ended 30 September 2025

| 2025 £
--- | ---
Turnover | 27,000
Income from coronavirus (COVID-19) business support grants | 0
Other Income | 0
Cost of Materials | ( 0 )
Staff Costs | ( 0 )
Depreciation and Writeoffs | ( 0 )
Other charges | ( 4,170 )
Tax on Profit | ( 0 )
Profit or (Loss) for Period | 22,830

# REFOLD THERAPEUTICS LIMITED

## Balance sheet

As at 30 September 2025

| 2025 £
--- | ---
Called up share capital not paid: | 0
Fixed Assets: | 0
Current assets: | 22,830
Prepayments and accrued income: | 0
Creditors: amounts falling due within one year: | ( 0 )
Net current assets (liabilities): | 22,830
Total assets less current liabilities: | 22,830
Creditors: amounts falling due after more than one year: | ( 0 )
Provision for liabilities: | ( 0 )
Accruals and deferred income: | ( 0 )
Total net assets (liabilities): | 22,830
Capital and reserves: | 22,830

# REFOLD THERAPEUTICS LIMITED

## Balance sheet continued

For the year ending 30 September 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 3 October 2025
And Signed On Behalf Of The Board By:

Name: Dr Thomas Crabbe
Status: Director

The notes form part of these financial statements

# REFOLD THERAPEUTICS LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 September 2025

- ## 1. Employee Information

  Average number of employees: 1

# REFOLD THERAPEUTICS LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 September 2025

- ## 2. Off balance sheet disclosure

  No